Word: novavax
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...biotech company Novavax, researchers are testing the use of virus-like particles (VLP), instead of the virus itself, to stimulate a flu immune response. Using this method, a vaccine for the 2009 H1N1 virus could be in production in 10 to 12 weeks, rather than the usual four to six months. "We have made vaccines against multiple flu strains and tested them in humans and gotten relevant and robust immune responses, which checks off the major boxes that the technology works against flu," says Rahul Singhvi, president and CEO of Novavax...
...Novavax's strategy involves isolating three proteins from the virus that flag the human immune system, which then churns out neutralizing antibodies against the proteins. These antibodies are robust enough to fight off the actual virus should an immunized person become infected. This is the same way the recently developed vaccine against human papilloma virus, Gardasil, works. "It provides the look and feel of the flu virus but does not have the genetic materials to cause disease," Singhvi says. (Read about the vaccine being prepared in case of a pandemic...
...doesn't grow well in chicken eggs; that could slash the yield and slow production of a potential new vaccine. "As long as we get the genetic sequence of some viral proteins, it doesn't matter where the virus came from - human, swine or bird," says Singhvi. So far, Novavax's shot is still in the testing phase, but its VLP-based vaccines against seasonal and bird flu are providing good results. The company stands ready to try its strategy against swine flu if needed. "The CDC is aware of what we are doing, and we have offered to help...
...these sites can range anywhere from personal opinion and speculation on stock values to meaningless chest-thumping and flame wars. But the majority of search terms sending traffic to today's message boards are stock symbols. TRMP (Trump Entertainment), MCZ (Mad Catz video game accessories), NVAX (vaccine maker Novavax), NPLA (InPlay Technologies) were the most popular over the last four weeks...
| 1 |